A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Abb Vie Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 42,138 shares of ABBV stock, worth $7.23 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
42,138
Previous 787,500 94.65%
Holding current value
$7.23 Million
Previous $122 Million 93.71%
% of portfolio
0.02%
Previous 0.31%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $119 Million - $136 Million
-745,362 Reduced 94.65%
42,138 $7.67 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $32.2 Million - $36.3 Million
-234,374 Reduced 22.94%
787,500 $122 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $53.6 Million - $62 Million
400,875 Added 64.55%
1,021,874 $152 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $54.1 Million - $67.3 Million
-407,901 Reduced 39.64%
620,999 $83.7 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $149 Million - $171 Million
1,028,900 New
1,028,900 $164 Million
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $2.65 Million - $3.58 Million
-32,955 Reduced 37.71%
54,446 $5.83 Million
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $13.8 Million - $16.2 Million
-160,627 Reduced 64.76%
87,401 $7.66 Million
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $83.9 Million - $112 Million
-1,142,878 Reduced 82.17%
248,028 $24.4 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $89.7 Million - $136 Million
1,390,906 New
1,390,906 $106 Million
Q3 2019

Nov 15, 2019

SELL
$62.98 - $75.72 $55.7 Million - $67 Million
-884,906 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $53.5 Million - $68.4 Million
814,776 Added 1161.81%
884,906 $64.4 Million
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $5.41 Million - $6.37 Million
70,130 New
70,130 $5.65 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $303B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.